Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Hangzhou Tigermed Consulting Co., Ltd., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 37.10x |
| P/B Ratio | 1.57x |
| P/S Ratio | 4.81x |
| Profitability | |
| Gross Margin | 27.4% |
| Operating Margin | 14.8% |
| Net Margin | 13.0% |
| EBITDA Margin | 20.8% |
| Liquidity | |
| Current Ratio | 2.18x |
| Quick Ratio | 2.16x |
| Leverage | |
| Debt/Equity | 0.07x |
YoY = year-over-year change. Source: FMP..